Citations

Clear

4847 citation(s) found for "Yu, Eric".

Molecular subtypes and outcomes in regorafenib-treated patients with metastatic colorectal cancer (mCRC) enrolled in the CORRECT trial.
Teufel, Michael, Schwenke, Susanne, Beckmann, Georg, Reischl, Joachim, Vonk, Richardus , Lenz, Heinz‐Josef , Jeffers, Michael , Wilhelm, Scott M., Wagner, Andrea, Laurent, Dirk, Kobina, Svetlana, Rutstein, Mark, Wirapati, Pratyaksha , Seidel, Henrik , Tabernero, Josep , Siena, Salvatore , Grothey, Axel , Cutsem, Eric Van , Wagner, Andrea, Guinney, Justin , Tejpar, Sabine

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3558-3558

10.1200/jco.2015.33.15_suppl.3558 Get It

Subgroup analysis of patients enrolled in the United States in the CORRECT phase 3 trial of the multikinase inhibitor regorafenib (REG) in metastatic colorectal cancer (mCRC).
Kim, George P., Lenz, Heinz‐Josef , Verma, Udit, Saltzman, Marc, Fuloria, Jyotsna, Khojasteh, Ali , Wiesenfeld, Martin, Cihon, Frank, Wagner, Andrea, Grothey, Axel, Cutsem, Eric Van , Wagner, Andrea

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e14649-e14649

10.1200/jco.2015.33.15_suppl.e14649 Get It

A model-based approach to dose optimization of neurotoxic chemotherapy for metastatic breast cancer (MBC).
Gray, Elizabeth, Mehrotra, Shailly , Wu, Kehua, Barry, William T., Hudis, Clifford A. , Lyss, Alan P., Toppmeyer, Deborah , Moreno‐Aspitia, Alvaro , Ratain, Mark J. , Sharma, Manish R. , Gray, Elizabeth, Winer, Eric P. , Rugo, Hope S. , Gobburu, Jogarao

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 1041-1041

10.1200/jco.2015.33.15_suppl.1041 Get It

Use of kZ‐space for high through‐plane resolution in multislice MRI: Application to prostate
Froemming, Adam T. , Grimm, Roger C., King, Bernard F., Stinson, Eric G. , Riederer, Stephen J. , Kargar, Soudabeh , Borisch, Eric A. , Kawashima, Akira

Mayo Clinic

Magnetic Resonance in Medicine | March 7, 2019 | Volume: 81 | Issue: 6 | Pages: 3691-3704

10.1002/mrm.27691 | PMID 30844092 Get It

PurposeThe goal of this work is to demonstrate 1 mm through‐plane resolution in multislice T2SE MRI using k‐space processing of overlapping slices and show applicability in prostate MRI.MethodsMultiple overlapped slices are acquired and Fourier transformed in the slice‐select direction. The slice profile is incorporated into a Tikhonov‐regularized reconstruction. Through‐plane resolution is tested in a resolution phantom. An anthropomorphic prostate phantom is used to study the SNR, and results are compared with theoretical prediction. The proposed method is tested in 16 patients indicated for clinical prostate MRI who gave written informed consent as overseen by our IRB. The “proposed” vs. “reference” multislice images are compared using multiple evaluation criteria for through‐plane resolution.ResultsThe modulation transfer function (MTF) plots of the resolution phantom show good modulation at frequency 0.5 lp/mm, demonstrating 1 mm through‐plane resolution restoration. The SNR measurements experimentally match the theoretically predicted values. The radiological evaluation shows that the proposed method is superior to the reference method for five criteria of sharpness but inferior with respect to artifacts.ConclusionsIn conjunction with overlapped slices a k‐space‐based reconstruction approach can be used to improve through‐plane resolution in multislice T2SE MRI. 1 mm resolution is demonstrated from 3.2 mm thick slices. The in vivo results from prostate MRI show improved sharpness when compared to the standard multislice method.
Dynamic discriminant model for predicting respiratory distress at birth based on mass volume ratio in fetuses with congenital lung malformation
Eyerly‐Webb, Stephanie A. , Nicolas, Clara T., Watson, D. , Dion, Éric , Amin, Ruchi , Wagner, Amy J., Lampland, Andrea, Bendel‐Stenzel, Ellen , Macardle, C. A., Jorgenson, Alissa , Lillegard, Joseph B. , Feltis, Brad A. , Eyerly-Webb, S , Feltis, B , Watson, D., Kunisaki, Shaun Michael

Mayo Clinic

Ultrasound in Obstetrics & Gynecology | March 5, 2019 | Volume: 54 | Issue: 6 | Pages: 759-766

10.1002/uog.20255 | PMID 30834623 Get It

ABSTRACTObjectivesThe congenital lung malformation volume ratio (CVR) is a prenatal ultrasound measurement that parameterizes congenital lung malformation (CLM) size. The aims of this study were to use serial measurements to create estimated growth curves of fetal CVR for asymptomatic and symptomatic neonates with CLM and to investigate whether a discriminant prognostic model based on these measurements could predict accurately which fetuses with CLM will require invasive respiratory support at delivery and should therefore be delivered at a tertiary‐care facility.MethodsThis was a retrospective study of fetuses diagnosed prenatally with CLM at three tertiary‐care children's hospitals between 2009 and 2016. Those with two or more sonographic measurements of CVR were included. Serial fetal CVR measurements were used to create estimated growth curves for neonates with and those without respiratory symptoms at delivery, defined as requiring invasive respiratory support for the first 24 h after delivery. A discriminant model based on serial CVR measurements was used to calculate the dynamic probability of the need for invasive respiratory support. The performance of this model overall and in preterm and term neonates was compared with those using maximum CVR thresholds of 1.0 and 1.6.ResultsOf the 147 neonates meeting the inclusion criteria, 16 (10.9%) required postnatal invasive respiratory support. The estimated CVR growth curve models showed different growth trajectories for asymptomatic and symptomatic neonates, with significantly higher CVR in symptomatic neonates, and values peaking late in the second trimester at around 25 weeks' gestation in asymptomatic neonates. All prognostic methods had high accuracy for the prediction of the need for invasive respiratory support in term neonates, but the discriminant model had the best performance overall (area under the receiver–operating characteristics curve (AUC) = 0.88) and in the preterm population (AUC = 0.85).ConclusionsThe estimated CVR growth curves showed different growth patterns in asymptomatic and symptomatic neonates with CLM. The dynamic discriminant model performed well overall and particularly in neonates that were carried to term. Development of an externally validated clinical tool based on this analysis could be useful in determining the site of delivery for fetuses with CLM. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.
Relationship between a Weighted Multi-Gene Algorithm and Blood Pressure Control in Hypertension
Phelps, Pamela, Kelley, Eli F. , Walla, Danielle, Ross, Jennifer , Simmons, Jerad, Bulock, Emma K, Ayres, Audrie, Akre, Monica K. , Sprissler, Ryan , Olson, Thomas P. , Snyder, Eric M.

Mayo Clinic

Journal of Clinical Medicine | March 1, 2019 | Volume: 8 | Issue: 3 | Pages: 289

10.3390/jcm8030289 | PMID 30823438 Get It

Hypertension (HTN) is a complex disease with interactions among multiple organ systems, including the heart, vasculature, and kidney with a strong heritable component. Despite the multifactorial nature of HTN, no clinical guidelines utilize a multi-gene approach to guide blood pressure (BP) therapy. Non-smokers with a family history of HTN were included in the analysis (n = 384; age = 61.0 ± 0.9, 11% non-white). A total of 17 functional genotypes were weighted according to the previous effect size in the literature and entered into an algorithm. Pharmacotherapy was ranked from 1–4 as most to least likely to respond based on the algorithmic assessment of individual patient’s genotypes. Three-years of data were assessed at six-month intervals for BP and medication history. There was no difference in BP at diagnosis between groups matching the top drug recommendation using the multi-gene weighted algorithm (n = 92) vs. those who did not match (n = 292). However, from diagnosis to nadir, patients who matched the primary recommendation had a significantly greater drop in BP when compared to patients who did not. Further, the difference between diagnosis to current 1-year average BP was lower in the group that matched the top recommendation. These data suggest an association between a weighted multi-gene algorithm on the BP response to pharmacotherapy.
SLC35A2‐CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals
Sosicka, Paulina , Agadi, Satish , Almannai, Mohammed , Bacino, Carlos A. , Barone, Rita , Burton, Jennifer, Carlston, Colleen M. , Cohen, Julie S. , Coman, David , Dipple, Katrina M. , Dorrani, Naghmeh, Dobyns, William B. , Elias, Abdallah F. , Epstein, Leon G. , Gahl, William A. , Garozzo, Domenico , Hammer, Trine Bjørg , Haven, Jaclyn, Héron, Delphine, Herzog, Matthew , Hoganson, George, Hunter, Jesse M. , Jain, Mahim , Juusola, Jane, Lakhani, Shenela , Lee, Hane , Lewis, Katherine, Mak, Christopher Chun Yu , McKnight, Dianalee , Mendelsohn, Bryce A. , Mignot, Cyril , Mirzaa, Ghayda , Mitchell, Wendy G. , Muhle, Hiltrud, Nelson, Stanley F. , Olczak, Mariusz , Palmer, Christina G.S. , Partikian, Arthur , Pierson, Tyler Mark , Regan, Brigid M. , Sacoto, María J. Guillen , Scaglia, Fernando , Scheffer, Ingrid E. , Segal, Devorah , Singhal, Nilika S. , Striano, Pasquale, Sturiale, Luisa , Symonds, Joseph D. , Willis, Mary , Wolfe, Lynne A. , Yano, Shoji , Powis, Zöe , Suchy, Sharon F., Edmondson, Andrew C. , Grünewald, Stephanie , Longo, Nicola , Mak, Christopher C Y , Patterson, Marc C. , Ross, M Elizabeth , Scheffer, Ingrid E , Symonds, Joseph , Edmondson, Andrew C , Ng, Bobby G. , Botto, Lorenzo D. , Chung, Hon-Yin B , Juusola, Jane , Lee, Joy Li-Yueh , Lewis, Katherine, Lourenco, Charles , Quinonez, Shane C. , Tang, Sha , Vilain, Eric J. N. , Yang, Hui , Rosenfeld, Jill A. , Freeze, Hudson H.

Mayo Clinic

Human Mutation | February 28, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/humu.23731 | PMID 30817854 Get It

Effect of Trinucleotide Repeat Expansion on the Expression ofTCF4mRNA in Fuchs' Endothelial Corneal Dystrophy
Okumura, Naoki , Hayashi, Ryosuke , Nakano, Masakazu , Yoshii, Kengo, Tashiro, Kei, Blake, Derek J. , Aleff, Ross A., Butz, Malinda L., Highsmith, Edward W., Wieben, Eric D. , Fautsch, Michael P. , Baratz, Keith H. , Komori, Yuya, Nakahara, Makiko , Tourtas, Theofilos , Schlötzer‐Schrehardt, Ursula , Kruse, Friedrich E., Koizumi, Noriko , Aleff, Ross, Butz, Malinda, Hayashi, Ryosuke, Sato, Takahiko

Mayo Clinic

Investigative Opthalmology & Visual Science | February 27, 2019 | Volume: 60 | Issue: 2 | Pages: 779

10.1167/iovs.18-25760 | PMID 30811544 Get It

Physician-Centered Outcomes for Skin Cancer Treatment: A Single-Day Modified Delphi Process to Assess the Importance of Themes in Skin Cancer Management
Sobanko, Joseph F. , Lawrence, Naomi, Bordeaux, Jeremy S. , Cartee, Todd V. , Armbrecht, Eric S. , Behera, Anit , Baum, Christian L. , Alam, Murad , Maher, Ian A. , Rossi, Anthony M., Alam, Murad

Mayo Clinic

Dermatologic Surgery | February 27, 2019 | Volume: 45 | Issue: 7 | Pages: 869-874

10.1097/dss.0000000000001835 | PMID 30807387 Get It

BACKGROUND Success in skin cancer treatment is determined through outcome measurement. Patients and physicians may prioritize different outcomes of care, and identification of such may enhance patient-centered care. OBJECTIVE To identify gaps between patient and physician attitudes toward skin cancer outcomes. MATERIALS AND METHODS A single-day, 21-patient, modified, in-person Delphi process to solicit and rate the importance of skin cancer–related outcomes was conducted. Twelve masked dermatologic surgeons rated patient-generated outcomes in a 2-round modified Delphi process. Each item was rated on a 1 to 9 scale (1, least important; 9, most important) using the Qualtrics web platform (Qualtrics, Provo, UT). Results of the physician ratings were compared with the patient ratings. RESULTS A list of 53 skin cancer treatment–related themes and outcomes was generated. Eight items were ranked by physicians as “very high” (>80% importance), 5 as “high” (>70% importance), 19 as intermediate, and 21 as low. The physician and patient panels' ratings were concordant for 56% of items, whereas 7 outcome items showed a 2-category discordance. CONCLUSION Physicians and patients were concordant regarding skin cancer treatment on multiple spheres. Areas of discordance include patient fear of unknown future risk, recurrence, or empowering patients to make treatment choices, and may be areas of continued improvement for delivery of patient-centered care.